Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis

Chester Lai; Suzannah August; Ramnik Behar; Marta Polak; Mike Ardern-Jones; Jeff Theaker; Aymen Al-Shamkhani; Eugene Healy

doi:10.1016/S0140-6736(15)60374-9

Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis

Lancet. 2015 Feb 26:385 Suppl 1:S59. doi: 10.1016/S0140-6736(15)60374-9.

Authors

Chester Lai¹, Suzannah August², Ramnik Behar², Marta Polak², Mike Ardern-Jones², Jeff Theaker³, Aymen Al-Shamkhani⁴, Eugene Healy²

Affiliations

¹ Dermatopharmacology, University of Southampton, Southampton, UK. Electronic address: [email protected].
² Dermatopharmacology, University of Southampton, Southampton, UK.
³ Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
⁴ Cancer Sciences, University of Southampton, Southampton, UK.

PMID: 26312881
DOI: 10.1016/S0140-6736(15)60374-9

Abstract

Background: Non-melanoma skin cancer is the most common cancer worldwide, and cutaneous squamous cell carcinomas (SCCs) account for substantial morbidity and mortality because of their potential for metastasis. SCCs are surrounded by an immune cell infiltrate containing regulatory T cells (Tregs). The aim of this study was to characterise Tregs in SCCs and investigate whether increased Treg numbers in primary skin SCCs are associated with subsequent metastasis.

Methods: Lymphocytes were extracted from freshly excised skin SCC tumours and corresponding peripheral blood and normal skin. Flow cytometry was used for T-cell analysis and cell sorting. Tritiated thymidine based lymphocyte proliferation assays and interferon γ (IFNγ) ELISPOT assays were used to assess peritumoral lymphocyte function in vitro. Immunohistochemistry was performed on primary cutaneous SCC sections from tumours that subsequently metastasised and from those that did not after 5-year follow-up.

Findings: Increased frequencies of CD3+CD4+CD25hiCD127loFOXP3+ Tregs were found in SCCs (21·5% of CD4+ immune infiltrate, n=60 tumours) compared with corresponding peripheral blood (5·4%) and normal skin (7·6%). SCC Tregs expressed significantly higher levels of the co-stimulatory molecules OX40 (37·2% of FOXP3+ cell population, n=10 tumours) and 4-1BB (12·6%, n=9) than peritumoral non-regulatory T cells and Tregs from peripheral blood and normal skin (p=0·0005). The inhibitory receptor CTLA4 and the transcription factor Helios were expressed at high levels in peritumoral Tregs. SCC Tregs significantly suppressed phytohaemagglutinin-stimulated peritumoral CD4+ T-cell proliferation (p=0·005, n=10), peritumoral CD8+ T-cell proliferation (p=0·015, n=9), and IFNγ secretion by CD4+ effector T cells (p=0·026, n=10). Increased in-vitro proliferation of phytohaemagglutinin-stimulated peritumoral CD4+ T cells was shown after the addition of anti-OX40 antibodies (p=0·0078, n=9 tumours) and anti-4-1BB antibodies (p=0·0039, n=9). Immunohistochemistry showed fewer CD8+ T cells in SCCs that metastasised (n=29) than in non-metastatic SCCs (n=26) (28·5% of immune infiltrate vs 44·6%%, p<0·0001) and more FOX3+ Tregs (28·5% of immune infiltrate vs 49·3%, p<0·0001).

Interpretation: Our study shows that immunosuppressive Tregs are present in the immune infiltrate of cutaneous SCCs, and contribute to ineffective anti-tumour immune responses, thereby permitting SCC development and promoting metastasis.

Funding: Wellcome Trust, National Institute for Health Research.

Abstract

Grants and funding